Cite

HARVARD Citation

    Péron, J. et al. (2019). Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit. Journal of the National Cancer Institute. pp. 1186-1191. [Online]. 
  
Back to record